Grusbakken 8
2820 Gentofte
Denmark
Phone: +45 45290000
Fax: +45 45290001
http://www.bioporto.com
info@bioporto.com
Manufacturers
OEM
Company Figures
Number of employees 20-49
Sales volume 1-9 Mio US $
Export content > 75%
Year of foundation 2001
Area of business Diagnostics
Company Profile
BioPorto Diagnostics A/S
BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector. The Company’s developments include a test (NGAL) to diagnose and monitor acute kidney damage.
BioPorto’s strategy is to develop new methods based on its antibody portfolio that can be patented and achieve a wide use in the diagnosis of various diseases.
BioPorto was founded in 2000 and has about 25 employees. The Company’s shares are listed on OMX Nordic Exchange Copenhagen (symbol: BIOPOR).